Icanheal secures Rs 15 Cr in seed round funding from IvyCap Ventures

Icanheal, a platform that intends to improve healthcare affordability and patient navigation, has secured an investment of Rs 15 crore from IvyCap Ventures. This investment aims to enhance Icanheal’s capabilities to cater to patients, particularly those facing critical care diseases like cancer, by providing customised healthcare financing solutions.

Icanheal with its wholly owned subsidiary Rx Consultants (RXCS) aims to address this critical gap by providing innovative healthcare financing solutions tailored to each patient’s needs. Whether through innovative access programs, easy-to-pay instalments or claims reimbursement, the solutions are designed with the aim to enhance accessibility and promote better adherence to treatments, thereby improving overall patient outcomes.

Vikram Gupta, Founder and Managing Partner, IvyCap Ventures will join the Icanheal board on behalf of IvyCap Ventures.